secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001964738-24-000017
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum Q2 GAAP EPS $0.51, adj EPS $1.56; raises full-year guidance
---------------------------------------------------------------------

- Reported sales $2.081B (+0.2% YoY); organic sales +1.3%; MedSurg and HIS drove growth.
- GAAP operating margin 11.7%; adjusted operating margin 20.7%; adjusted EPS $1.56.
- Generated $355M cash from ops; free cash flow $297M.
- Raises full-year 2024 organic sales growth and adjusted EPS guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000196473824000017/0001964738-24-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000196473824000017/solv-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001964738-24-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer